Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lipopolysaccharide (Pseudomonas aeruginosa) (LPS)
- Target
- LPS
- Molecular classification
- Glycolipid, Outer membrane component
01
Overview
Lipopolysaccharide (LPS) is a major component of the outer membrane of Pseudomonas aeruginosa and other Gram-negative bacteria. It consists of lipid A, a core oligosaccharide, and an O-antigen. LPS acts as a protective barrier and triggers strong innate immune responses via TLR4 signaling. Its structural variability contributes to immune evasion, biofilm formation, and antibiotic resistance, making it a key virulence factor. Therapeutic strategies target LPS biosynthesis, transport, or its interaction with TLR4; however, heterogeneity complicates direct targeting.
- Other names
- P. aeruginosa LPSPseudomonas LPSLipopolysaccharide
02
Mechanism of action
Inhibition of LPS biosynthesis, disruption of LPS transport/assembly, TLR4 antagonism
03
Biological functions
Barrier functionImmune stimulationAdhesionBiofilm formationVirulenceAntibiotic resistance
04
Disease associations
InfectionSepsisInflammationCystic fibrosis exacerbation
05
Safety considerations
Potential for off-target effects due to structural heterogeneityRisk of inducing endotoxin shock upon lysis of bacteriaDevelopment of resistance through LPS modification
Beyond the preview
Go deeper on Lipopolysaccharide (Pseudomonas aeruginosa) (LPS).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lipopolysaccharide (Pseudomonas aeruginosa) (LPS).